INCIDENCE OF ENDOMETRIAL CANCER IN WOMEN WITH POST MENOPAUSAL BLEEDING ON HYSTEROSCOPIC ENDOMETRIAL SAMPLING

Main Article Content

Dr Nayab Mohiuddin
Dr. Uzma Shabab
Dr. Qurat Ul Aman Siddiqui
Dr. Nudrat Tanveer

Keywords

Endometrial cancer, post-menopausal bleeding, hysteroscopy, incidence

Abstract

Background and Aim: Endometrial carcinoma (EC) is the most common cancer among women in developed countries, accounting for approximately five percent of all cancer cases and exhibiting a global morbidity rate of up to 2% in women. The present study aimed to determine the frequency of endometrial cancer in women with postmenopausal bleeding (PMB) on hysteroscopic guided dilatation and curettage at a tertiary care hospital in Karachi.


 


Patients and Methods: A descriptive cross-sectional study was carried out on 149 post-menopausal bleeding patients in the Obstetrics and Gynecology Department at Liaquat National Hospital, Karachi. Patients (age >45 years) with postmenopausal bleeding who underwent hysteroscopy guided dilatation and curettage were enrolled. Patient age, past medical and gynecological history, medical records, and endometrial thickness on ultrasound, pathology, and diagnosis were recorded. SPSS version 22 was used for descriptive statistics.


 


Results: The overall mean age of patients was 56.28±8.46 years. Patients were distributed based on their age groups as follows; 44 (29.5%) in 45-55 years, 86 (57.7%) 56-65 years, and 19 (12.8%) >65 years. Majority of patients 112 (75.2%) belonged to rural areas and 88 (59.1%) were illiterate. The incidence of nulliparous and multiparous was 43% (n=64) and 57% (n=85) respectively. Of the total 149 PMB cases, the incidence of malignancy was 20.1% (n=30). Benign endometrial polyps was the most prevalent 56 (37.6%) histopathological findings on hysteroscopy followed by uterine cancer (polypoidal growth) 30 (20.1%), simple hyperplasia and cystic hyperplasia 28 (18.8%), hyperplasia with atypia 19 (12.8%), normal-proliferative endometrium 9 (6%), and benign endocervical polyps 7 (4.7%). Out of 30 polypoidal growth cases, the incidence of endometrial adenocarcinoma, endocervical carcinoma, and uterine sarcoma (large polypoidal growths) was 22 (73.3%), 3 (10%), and 5 (16.7%) respectively.


 


Conclusion: The present study found that the incidence of malignancy was 20.1% in PMB women. The gold standard protocol for PMB cases consists of hysteroscopy-guided curettage with subsequent histopathological examination.


 

Abstract 37 | PDF Downloads 19

References

1. Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal, “Cancer Statistics, 2017”, CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
2. Charles Gaber, Rafael Meza1, Julie J. Ruterbusch etal “Endometrial Cancer Trends by Race and Histology in the USA: Projecting the Number of New Cases from 2015 to 2040”, J Racial Ethn Health Disparities. Author manuscript; available in PMC 2019 December 18.
3. Smittenaar CR, Petersen KA, Stewart K, Moitt N. Cancer incidence and mortality projections in the UK until 2035. Br J Cancer. 2016;115(9):1147-55
4. C R Smittenaar, K A Petersen, K Stewart, N Moitt, “Cancer incidence and mortality projections in the UK until 2035”, Br J Cancer. 2016 Oct 25;115(9):1147-1155. doi: 10.1038/bjc.2016.304. Epub 2016 Oct 11.
5. Eleanor R Jones, Helena O’Flynn, Kelechi Njoku etal, “Detecting endometrial cancer”, TOG The Obstetrician & Gynaecologist, Volume 23, Issue 2, April, 2021, Pages 103-112,
https://doi.org/10.1111/tog.12722.
6. Sundar S, Balega J, Crosbie E, Drake A, Edmondson R, Fotopoulou C, et al. BGCS uterine cancer guidelines: recommendations for practice. Eur J ObstetGynecolReprod Biol. 2017;213:71–97.
7. Giancarlo Garuti, Stefano Angioni, Liliana Mereu etal, Hysteroscopic view with targeted biopsy in the assessment of endometrial carcinoma. What is the rate of underestimatated diagnosis? The results of a multicenter Italian trial”, Garuti et al. Gynecological Surgery (2020) 17:10, https://doi.org/10.1186/s10397-020-01077-0.
8. Garuti G, Angioni S, Mereu L, Calzolari S, Mannini L, Scrimin F, Casadio P, De Alberti D, Nappi L, Busato E, Leone FP. Hysteroscopic view with targeted biopsy in the assessment of endometrial carcinoma. What is the rate of underestimated diagnosis? The results of a multicenter Italian trial. Gynecological Surgery. 2020 Dec;17(1):1-7.
9. Devabhaktuni P, Allani P, Komatlapalli S, Ksheerasagara RR. Hysteroscopy in one hundred cases of postmenopausal uterine bleeding, in the detection of uterine cancer and atypical endometrial hyperplasia. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2020 Jun 1;9(6):2253-62.
10. Melhouf A. Correlation between Ultrasound, Hysteroscopy and Histology in the Exploration of Postmenopausal Metrorrhagia (about 90 Cases). Reproductive Sciences. 2023;7:2.
11. Ding Y, Han Y, Zhang S, Shi X. The incidence of unexpected uterine malignancies in hysterectomies carried out for benign indications. Journal of Cancer Research and Clinical Oncology. 2023 Jul;149(8):4339-45.
12. Carugno JMS, LaganÀ AS, Vitale SG, Alonso L, SpiezioDI SA, Haimovich S (2021) New development on hysteroscopy for endometrial cancer diagnosis: state of the art. Minerva Med 112(1):12–19
13. Desai VB, Wright JD, Gross CP, Lin H, Boscoe FP, Hutchison LM et al (2019) Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy. Am J of Obstetr Gynecol 221(1):39.e1-39.e14
14. Gkrozou F, Dimakopoulos G, Vrekoussis T, Lavasidis L, Koutlas A, Navrozoglou I et al (2015) Hysteroscopy in women with abnormal uterine bleeding: a meta-analysis on four major endometrial pathologies. Arch Gynecol Obstet 291(6):1347–1354.
15. Lee YL, Bai YS, Yin CS. Vaginoscopic hysteroscopy in management for women with postmenopausal vaginal bleeding. Taiwan J Obstet Gynecol. 2019;58:497e500.
16. Multinu F, Casarin J, Tortorella L, Huang Y, Weaver A, Angioni S et al (2019) Incidence of sarcoma in patients undergoing hysterectomy for benign indications: a population-based study. Am J Obstetr Gynecol 220(2):179.e1-179.e10
17. Tsuda H, Ito YM, Todo Y, Iba T, Tasaka K, Sutou Y et al (2018) Measurement of endometrial thickness in premenopausal women in office gynecology. Reprod Med Biol 17(1):29–35
18. Di Spiezio SA, Saccone G, Carugno J, Pacheco LA, Zizolfi B, Haimovich S, Clark TJ (2022) Endometrial biopsy under direct hysteroscopic visualization versus blind endometrial sampling for the diagnosis of endometrial hyperplasia and cancer: systematic review and meta-analysis. Facts Wiews Vis Obgyn 14:103–110. https://doi.org/10.52054/FVVO.14.2.023
19. Zhang C, Wang EY, Liu F, Sung CJ, Quddus MR, Ou J, Lomme M, Lawrence WD (2018) Routine histologic features in complex atypical hyperplasia can predict the presence of endometrial carcinoma: a clinicopathological study of 222 cases. Hum Pathol 80:40–46.
https://doi.org/10.1016/j.humpath.2018.03.009
20. Singh P, Dwivedi P, Mendiratta S. Correlation of endometrial thickness with the histopathological pattern of endometrium in postmenopausal bleeding. J Obstet Gynaecol India. 2016;66(1):42-6
21. Devabhaktuni P, Suneeta K, Kancharla K. Role of hysteroscopy and endometrial curettage in postmenopausal women with and without postmenopausal bleeding. Gynecol Obstet Open Acc. 2018:OBOA-125.
22. Begum J, Samal R. A clinicopathological evaluation of postmenopausal bleeding and its correlation with risk factors for developing endometrial hyperplasia and cancer: a hospital-based prospective study. J Midlife Health. 2019;10:179–83.